This test is most useful if any of these apply to you.
Your standard blood count quietly tracks five types of white blood cells. Eosinophils are one of the smaller slices (basophils are typically smaller still), usually only a few percent, but when that slice shifts, it can point to allergies driving symptoms you have not connected to your immune system, parasites you did not know you had, or in rare cases blood disorders that warrant urgent workup.
Eosinophils % (the percentage of eosinophils among all white blood cells) is one of the few markers on a routine panel that captures type 2 immune activity, the kind of inflammation that drives asthma, eczema, hives, and food and environmental allergies. Read alongside the rest of your differential, it is a low-cost early signal for problems that often hide behind 'normal-looking' bloodwork.
Eosinophils are immune cells made in your bone marrow. They circulate briefly in your blood, then migrate into tissues such as the gut lining, skin, and airways, where they release packets of proteins and signaling molecules to attack parasites and coordinate allergic responses. In healthy adults, eosinophils make up a small fraction of circulating white blood cells, and population studies place the typical value in the low single digits as a percentage.
Because the percentage depends on both the eosinophil number and the total white blood cell count, doctors often pair it with the absolute eosinophil count (the actual number of eosinophils per microliter of blood). The percentage can look normal even when the absolute count is abnormal, and the reverse is also true. The two together give the clearest read.
Elevated eosinophils are a hallmark of allergic disorders, including asthma, allergic rhinitis (hay fever), and atopic dermatitis (eczema). The cells are recruited and activated by the same signaling chemicals (IL-4, IL-5, IL-13) that drive these conditions, and the blood count reflects how active that pathway is.
For asthma in particular, blood eosinophils are among the best-established biomarkers for picking a treatment. Patients with higher counts tend to respond better to inhaled and systemic steroids and to targeted biologic drugs. In a study of children with uncontrolled moderate-to-severe asthma, higher baseline eosinophil levels predicted both greater exacerbation risk and stronger response to a biologic medication. In adult-onset eosinophilic asthma, elevated eosinophils mark a harder-to-control subgroup with more flares, worse lung function, and more nasal polyps.
In COPD (chronic obstructive pulmonary disease), eosinophils tell a more complex story. In stable COPD, a percentage at or above 2% has been associated with a higher risk of exacerbation over the next year compared with patients below that threshold, although results have varied across cohorts and current GOLD guidance does not endorse blood eosinophils alone as a reliable individual predictor of exacerbations. Higher eosinophils also predict better response to inhaled steroids.
The picture flips during acute COPD flares that land people in the hospital. Patients admitted with very low eosinophils had a meaningfully higher risk of in-hospital death in a large prospective study, along with higher rates of ICU admission and the need for a breathing machine. So in stable disease, higher eosinophils flag risk and treatment response, while in the hospital, very low values often mark the sickest patients.
These two findings sound contradictory but are not. Eosinophils % behaves more like a phenotype indicator than a simple 'good or bad' number. Higher values in stable patients identify allergic-type airway inflammation that responds to specific drugs. Very low values during a severe flare often reflect overwhelming systemic stress that pulls eosinophils out of circulation, which is a marker of how sick the body is, not of the airway disease itself.
Above certain levels, eosinophils themselves cause organ damage by releasing toxic granule proteins into tissues. Doctors describe absolute counts above 500 cells per microliter as eosinophilia, and counts at or above 1,500 cells per microliter as hypereosinophilia. Persistent values in the hypereosinophilic range warrant a full workup for hypereosinophilic syndromes, the autoimmune disorder eosinophilic granulomatosis with polyangiitis, eosinophilic esophagitis, eosinophilic pneumonia, and certain blood cancers driven by mutations such as FIP1L1-PDGFRA fusion.
Isolated, symptom-free eosinophilia can be the earliest sign of hypereosinophilic syndrome, which is why an unexplained, sustained elevation should not be ignored just because you feel fine. Quiet eosinophil-driven inflammation can damage the heart, lungs, nerves, and skin before symptoms appear.
Eosinophils evolved largely to attack parasitic worms. A persistently elevated percentage, especially with relevant travel history or exposure, should prompt testing for helminth infections. A caveat: in chronic parasitic infections such as paragonimiasis (a lung fluke), eosinophils may normalize once the parasites settle in tissues, so a normal value does not rule out parasitic disease in someone with suggestive symptoms.
Very low eosinophil percentages, called eosinopenia, show up in acute severe illness. In COVID-19, eosinopenia tracked closely with disease severity, with one retrospective study reporting it in about 74% of mild cases, 87% of moderate cases, and 94% of severe cases. Severe diabetic ketoacidosis also lowers eosinophils, with values rebounding as the patient recovers. A meta-analysis of patients with infections found that low eosinophils and a failure to recover were associated with worse mortality risk.
Low eosinophils on a routine, healthy person's blood draw are usually not concerning by themselves. The signal carries weight mainly in the setting of acute illness, where it reflects how much physiologic stress your body is under.
Eosinophil counts move with the seasons, the time of year, and the time you draw the blood. In one large stability analysis, eosinophil counts shifted by about 20% between seasons, with the highest values often in spring as allergens peak. Mid-range values are the least stable, with fewer than half of patients staying in the same category across repeated measurements over a year. A single reading near a decision threshold should be confirmed.
A reasonable cadence: get a baseline, repeat in 3 to 6 months if you are making changes such as adjusting allergy treatment, starting or stopping a steroid, or investigating an unexplained elevation, then at least annually as part of a routine complete blood count. If you see an unexpected high or low value, retest before drawing conclusions. Trending over multiple draws is far more reliable than reacting to one number.
An out-of-pattern eosinophil percentage is rarely diagnostic on its own. What matters is the combination. If your percentage is elevated, the first step is to confirm with a repeat draw and look at the absolute eosinophil count, which is the number doctors actually use to grade severity. From there, the workup depends on what is on the rest of your panel and your symptoms.
A persistently elevated count without an obvious cause warrants conversations about allergy testing, parasite screening if you have relevant exposures, and, if values reach the hypereosinophilic range, referral to a hematologist or allergist for evaluation of eosinophilic syndromes. Companion tests that help interpret eosinophils include total IgE and specific allergy testing, fractional exhaled nitric oxide for airway inflammation, tryptase and vitamin B12 if hypereosinophilic syndrome is suspected, and stool studies if parasitic infection is plausible. A very low percentage during acute illness usually does not need workup on its own but should be tracked alongside the rest of the clinical picture.
Evidence-backed interventions that affect your Eosinophils % level
Eosinophils % is best interpreted alongside these tests.